Bullish vs. Bearish (5 opinions)
Social Sentiment 0.13
AIMT Forecast and Technical Stock Analysis
Buy candidate since 2019-09-13 Loss -8.15% PDF
Aimmune Therapeutics gained 0.71% in the last trading day ( Friday, 20th Sep 2019 ), rising from $22.50 to $22.66 During the day the stock fluctuated 3.43% from a day low at $22.45 to a day high of $23.22. The price has fallen in 5 of the last 10 days , but is still up by 10.21% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.75 million more shares were traded than the day before. In total, 1.60 million shares bought and sold for approximately $36.35 million.
- 30 day high of the AIMT stock price was $26.81 and low was $18.94.
- 90 day high was $26.81 and low was $16.95.
- 52 week high for Aimmune Therapeutics - $36.12 and low - $16.95.
Aimmune Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.23% during the next 3 months and, with 90% probability hold a price between $22.38 and $28.92 at the end of this period.
Only positive signals in the chart today. Aimmune Therapeutics holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $23.27. On a fall, the stock will find some support from the long-term average at approximately $20.97. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Tuesday September 17, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 59 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Aimmune Therapeutics finds support from accumulated volume at $22.38.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.77 between high and low, or 3.43%. For the last week, the stock has had a daily average volatility of 6.52%.
Our recommended stop-loss: $21.19 (-6.49%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 3 days ago.)
6.52 %Average volatility
Very Low Low Medium High Very High
|AIMT $22.66 ($0.16 0.71%)|
AIMT is up $0.16 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AIMT based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AIMT analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!